Navigation Links
Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study

eissComm Partners, +1-415-946-1064

Web site: http://www.medivation.com/

Ticker Symbol: (NASDAQ-NMS:MDVN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
2. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
3. Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces Presentation of Full Top-Line Data From Dimebon Six-Month Trial at Major International Alzheimers Disease Conference
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
8. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
9. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
11. Tercica to Present at Investment Conferences
Post Your Comments:
(Date:3/2/2015)... March 2, 2015 Cure SMA recently announced a ... Biomedical Research (CALIBR). This funding is an extension of a ... a $700,000 Cure SMA grant to Dr. Peter G. ... "Optimization of Small Molecules that Increase SMN2 Levels ... motor neuron (SMN) protein is critical to the function of ...
(Date:3/2/2015)... -- Landauer, Inc. (NYSE: LDR ), a recognized ... outsourced medical physics services and high quality medical consumable ... the fiscal first quarter 2015 after the market close ... Company will also host a conference call for investors ... Time (10:00 a.m. Eastern Time). Investors may access the ...
(Date:3/2/2015)... March 2, 2015 Amgen (NASDAQ: ... abstracts, including data evaluating Repatha TM (evolocumab), an ... investigational drug for chronic heart failure, at the upcoming ... Session (ACC.15), being held March 14-16 in ... fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin ...
Breaking Medicine Technology:Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 3Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 2Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 3Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 4Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 5Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 6Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 7Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 8Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 9Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 10Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data 11
... Most Up-to-Date Analysis of the Alzheimer,s Disease Market Now ... ... WALTHAM, Mass., July 15 Decision Resources, one ... and,healthcare issues, finds that with Myriad Genetics/Lundbeck,s decision to,discontinue ...
... for diseases of ... ... Pharmaceuticals, Inc.,a privately held biotechnology company located in San Jose, CA, ... from Penwest Pharmaceuticals, Edison,s development,partner. Penwest has begun dosing in a ...
Cached Medicine Technology:Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2Edison Pharma Hits Milestone as A0001 Enters Phase 1 Clinical Development 2
(Date:3/3/2015)... When a lifeguard is on duty, it is important for him ... loose clothing. For a lifeguard, comfort can mean not allowing ... the guard prefers to cover up. Comfort also means staying warm ... the clothing that fits correctly. When a lifeguard is spending ... that the guard stays warm and comfortable throughout the shift. ...
(Date:3/3/2015)... NY (PRWEB) March 03, 2015 ... high-quality, clinically-based care management programs and a member ... the appointment of Julie O’Brien as President. O’Brien ... Chief Operating Officer. In her new role, she ... for all aspects of AMM’s call center operations, ...
(Date:3/3/2015)... Dr. Stephen Edgerton, a ... has achieved Accredited Member Status in the American ... this accomplishment after completing a rigorous credentialing process ... the submission of clinical cases for examination. ... up in Connecticut, Charlotte, North Carolina, Caracas, Venezuela ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... research networking-technology corporation, announced today that it has ... the Clinical Data Interchange Standards Consortium (CDISC). HCP ... effort to standardize knowledge-based training and certifications globally. ... IT and web support as well as development ...
(Date:3/3/2015)... Aliso Viejo, California (PRWEB) March 03, 2015 ... new animated effect entitled inMotion3D Environment from Pixel Film ... turns a 2D HDRI image into 360° viewing area ... Film Studios. “inMotion3D Environment blurs the line between professional ... , Motion 5 users can turn their 2D HDRI ...
Breaking Medicine News(10 mins):Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 2Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 3Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 4Health News:Julie O'Brien Named President of AliCare Medical Management 2Health News:Julie O'Brien Named President of AliCare Medical Management 3Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 2Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 3Health News:A New Plugin Entitled inMotion3D Environment Was Released Today from Pixel Film Studios Exclusively for Motion 5 2
... Delhi is planning to interlink its major 29 hospitals ... and treatment provided. This computerization and interlinking of data ... by which doctors can know the case history and ... modules of software to deal with different hospital departments. ...
... number of psychiatric disorders, including mood disorders, schizophrenia// ... shown to increase the risk for emergence of ... disorder), and that presence of certain anxiety disorders ... development of nicotine dependence. ,A recent study ...
... or growing fast: systematic review of size and growth ... who grow rapidly during the first two years of life, ... a study reveals. ,There is an urgent need to ... is not clear how early in life prevention could begin. ...
... is no link whatsoever between breast cancer and cholesterol levels ... control the same. ,The details of the study ... Internal Medicine, one of the JAMA/Archives journals. The article says ... to suggest that the statins may work in conjunction with ...
... compulsory licensing (CL) provision in the Patents Act that ... Swiss drug maker Roche’s patented drug Tamiflu, useful in ... flu virus. , ,Section 92 empowers the government ... the industry. Furthermore, the issue of such license is ...
... a large, heterogeneous group of rare pulmonary disorders ... abnormal gas exchange with considerable mortality and morbidity. ... diagnosis includes more than 100 conditions in both ... and Colorado conducted a descriptive, observational study was ...
Cached Medicine News:Health News:Delhi Government To Interlink All Major Hospitals Through e-Governance 2Health News:Smokers Are Prone To Number Of Psychiatric Disorders 2Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2
... for Toxoplasmosis has progressed from ... dye test to immunoflourescence, latex ... In addition to Toxo ... both Toxo IgM immunocapture and ...
... safe, effective and relatively bloodless procedure for ... easy to learn and can be performed ... outpatient setting with few if any patient ... minimize OR time and use a familiar ...
... generally confirmed by a positive heterophil antibody test ... not indicated by the heterophil antibody test. ... percent of children. Detection and identification of ... the stage of EBV infection. Bio-Rad offers ...
... can lower healthcare costs with better newborn ... identifying mothers colonized with group B streptococcus ... effective antibiotic prophylaxis. This can prevent illness ... reduce unnecessary antibiotic use in uncolonized women ...
Medicine Products: